Literature DB >> 9137119

Aberrant semantic activation in schizophrenia: a neurophysiological study.

P G Nestor1, M O Kimble, B F O'Donnell, L Smith, M Niznikiewicz, M E Shenton, R W McCarley.   

Abstract

OBJECTIVE: Schizophrenia has long been thought to be characterized by a fundamental disturbance in semantic associations, which has often been presumed to be of neurobiological origin. The authors examined the neurophysiological characteristics of semantic processing in schizophrenic patients.
METHOD: During EEG recording, 15 schizophrenic patients and 15 age-matched comparison subjects read sentences that had either sensible or nonsensical endings. The authors recorded the N400 component, a specific negative event-related brain potential occurring approximately 400 msec after the final word in the sentence. N400 is highly, if not uniquely, sensitive to semantic expectancy and context, and larger, more negative N400 amplitude is associated with increased semantic unexpectancy.
RESULTS: In relation to the normal comparison subjects, the schizophrenic patients demonstrated prolonged N400 latency after nonsensical sentence endings and also showed enhanced N400 negativity, regardless of the sense of the sentence ending.
CONCLUSIONS: These findings suggest slower and more diffuse semantic activation in patients with schizophrenia, perhaps reflective of a disease-related failure to maintain and to use semantic context.

Entities:  

Mesh:

Year:  1997        PMID: 9137119     DOI: 10.1176/ajp.154.5.640

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  28 in total

1.  Event-related potentials elicited during a context-free homograph task in normal versus schizophrenic subjects.

Authors:  D F Salisbury; B F O'Donnell; R W McCarley; P G Nestor; M E Shenton
Journal:  Psychophysiology       Date:  2000-07       Impact factor: 4.016

Review 2.  Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects.

Authors:  R W McCarley; M A Niznikiewicz; D F Salisbury; P G Nestor; B F O'Donnell; Y Hirayasu; H Grunze; R W Greene; M E Shenton
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

Review 3.  Semantics and N400: insights for schizophrenia.

Authors:  Namita Kumar; J Bruno Debruille
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

4.  Negative expectancies in posttraumatic stress disorder: neurophysiological (N400) and behavioral evidence.

Authors:  Matthew Kimble; Laura Batterink; Elizabeth Marks; Cordelia Ross; Kevin Fleming
Journal:  J Psychiatr Res       Date:  2012-05-16       Impact factor: 4.791

Review 5.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

6.  An fMRI study of semantic processing in men with schizophrenia.

Authors:  M Kubicki; R W McCarley; P G Nestor; T Huh; R Kikinis; M E Shenton; C G Wible
Journal:  Neuroimage       Date:  2003-12       Impact factor: 6.556

7.  Effects of alcohol on verbal processing: an event-related potential study.

Authors:  Ksenija Marinkovic; Eric Halgren; Irving Maltzman
Journal:  Alcohol Clin Exp Res       Date:  2004-03       Impact factor: 3.455

Review 8.  Neurocognitive mechanisms of conceptual processing in healthy adults and patients with schizophrenia.

Authors:  Tatiana Sitnikova; Christopher Perrone; Donald Goff; Gina R Kuperberg
Journal:  Int J Psychophysiol       Date:  2009-12-07       Impact factor: 2.997

9.  Abnormal semantic processing in females with fragile X-associated tremor/ataxia syndrome.

Authors:  J-C Yang; C Simon; A Schneider; A L Seritan; L Hamilton; P J Hagerman; R J Hagerman; J M Olichney
Journal:  Genes Brain Behav       Date:  2013-12-26       Impact factor: 3.449

Review 10.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.